These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17475579)

  • 1. Initial lymph node dissection increases cure rates in patients with medullary thyroid cancer.
    Greenblatt DY; Elson D; Mack E; Chen H
    Asian J Surg; 2007 Apr; 30(2):108-12. PubMed ID: 17475579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
    Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
    Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
    Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
    J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas.
    Weber T; Schilling T; Frank-Raue K; Colombo-Benkmann M; Hinz U; Ziegler R; Klar E
    Surgery; 2001 Dec; 130(6):1044-9. PubMed ID: 11742336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medullary thyroid cancer: prognostic factors for survival and recurrence, recommendations for the extent of lymph node dissection and for surgical therapy in recurrent disease.
    Pilaete K; Delaere P; Decallonne B; Bex M; Hauben E; Nuyts S; Clement P; Hermans R; Vander Poorten V
    B-ENT; 2012; 8(2):113-21. PubMed ID: 22896930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of primary surgical therapy on the course of C-cell carcinoma of the thyroid gland].
    Colombo-Benkmann M; Raff J; Raue F; Klar E; Herfarth C
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1041-3. PubMed ID: 9931784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
    Linder R; Fuhrmann J; Hammerschmidt D
    Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
    Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
    Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of lymph node metastases on survival in pediatric medullary thyroid cancer.
    Raval MV; Sturgeon C; Bentrem DJ; Elaraj DM; Stewart AK; Winchester DJ; Ko CY; Reynolds M
    J Pediatr Surg; 2010 Oct; 45(10):1947-54. PubMed ID: 20920711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management and follow-up of medullary thyroid carcinoma.
    Marzano LA; Porcelli A; Biondi B; Lupoli G; Delrio P; Lombardi G; Zarrilli L
    J Surg Oncol; 1995 Jul; 59(3):162-8. PubMed ID: 7609522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma: An Israeli Multicenter Study.
    Hirsch D; Twito O; Levy S; Bachar G; Robenshtok E; Gross DJ; Mazeh H; Benbassat C; Grozinsky-Glasberg S
    Thyroid; 2018 Mar; 28(3):369-376. PubMed ID: 29402183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
    Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
    Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective lateral compartment neck dissection for thyroid cancer.
    Welch K; McHenry CR
    J Surg Res; 2013 Sep; 184(1):193-9. PubMed ID: 23816244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term prognosis of medullary thyroid carcinoma in 39 patients.
    Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
    Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic variables and calcitonin in medullary thyroid cancer.
    Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
    Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medullary thyroid carcinoma (MTC)--clinical and molecular aspects on the basis of own experience.
    Pomorski L; Bartkowiak J; Pisarek H; Bartos M; Narebski J
    Neoplasma; 2000; 47(5):323-6. PubMed ID: 11130252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.
    Esfandiari NH; Hughes DT; Yin H; Banerjee M; Haymart MR
    J Clin Endocrinol Metab; 2014 Feb; 99(2):448-54. PubMed ID: 24276457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?
    Alvarado R; Sywak MS; Delbridge L; Sidhu SB
    Surgery; 2009 May; 145(5):514-8. PubMed ID: 19375610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
    Skinner MA; Wells SA
    Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.